Citation Impact
Citing Papers
Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X L
2019
Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**
2021 StandoutNobel
Degradation of proteins by PROTACs and other strategies
2019
Advances in targeted degradation of endogenous proteins
2019
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
2020
Construction of ecological security pattern of national ecological barriers for ecosystem health maintenance
2022 Standout
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
2020
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
2021
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
2020
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
2020
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
2020
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
2020
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
2020
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
2020
Targeted protein degradation: expanding the toolbox
2019
PROTAC targeted protein degraders: the past is prologue
2022 Standout
In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
2021
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
2020
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Crystal Structures of Protein-Bound Cyclic Peptides
2019
Rocky desertification in Southwest China: Impacts, causes, and restoration
2014 Standout
PROTAC-DB: an online database of PROTACs
2020
Conservation Agriculture as a Sustainable System for Soil Health: A Review
2022 Standout
Increased vegetation growth and carbon stock in China karst via ecological engineering
2018 Standout
The application of geospatial techniques in monitoring karst vegetation recovery in southwest China
2017
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality
2019
Current strategies for the design of PROTAC linkers: a critical review
2020
Optimizing urban ecological space based on the scenario of ecological security patterns: The case of central Wuhan, China
2021
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
2021
Effects of Soil Aggregate Stability on Soil Organic Carbon and Nitrogen under Land Use Change in an Erodible Region in Southwest China
2019
Recent Advances in the Chemical Synthesis of C-Glycosides
2017
Works of Yangbing Li being referenced
Soil erosion evolution and spatial correlation analysis in a typical karst geomorphology using RUSLE with GIS
2017
Abstract 4870: Targeted MDM2 degradation as a novel and efficacious cancer therapy
2018
Synthesis of orthogonally protected l-glucose, l-mannose, and l-galactose from d-glucose
2012
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
2019
Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.
2019
The relations between land use and karst rocky desertification in a typical karst area, China
2008
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
2018
Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction
2017